What do systematic reviews say?

Baclofen vs placebo

• Baclofen for alcohol use disorder 2023 · Cochrane Headline outcomes only
  no estimate extracted
  13 studies · 840 participants
  Moderate

Baclofen vs placebo

• Baclofen for alcohol use disorder 2023 · Cochrane Headline outcomes only
  no estimate extracted
  9 studies · 392 participants
  Moderate

Totally tubeless PNL vs standard PNL

• Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 274 participants
  Moderate

Totally tubeless PNL vs standard PNL

• Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 50 participants
  Very low

Tubeless PNL vs standard PNL

• Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 186 participants
  Low

Tubeless PNL vs standard PNL

• Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 238 participants
  Low

Tubeless PNL vs standard PNL

It is very uncertain whether tubeless PNL changes readmission (first 30 days) MCID: 50 per 1000 compared with standard PNL (very low certainty).

• Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
  RR 1 [0.07, 14.21]
  1 study · 24 participants
  Very low

Totally tubeless PNL vs standard PNL

• Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 50 participants
  Low

Tranexamic acid vs placebo (saline solution or sterile water)

Tranexamic acid showed no clear difference in postoperative bleeding (place of packing or revision surgery within… compared with placebo (saline solution or sterile water) (low certainty).

• Tranexamic acid for the reduction of bleeding during functional endoscopic sinus surgery 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 404 participants
  Low

Summary of findings table ‐ Quality and volume of gastric residual vs quality of gastric residual alone

• Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 87 participants
  Low

Summary of findings table ‐ Quality and volume of gastric residual vs quality of gastric residual alone

• Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 87 participants
  Low

Summary of findings table ‐ routine monitoring vs no routine monitoring of gastric residual

• Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 334 participants
  Moderate

Summary of findings table ‐ routine monitoring vs no routine monitoring of gastric residual

• Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Low

Summary of findings table ‐ routine monitoring vs no routine monitoring of gastric residual

• Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 334 participants
  Moderate

Summary of findings table ‐ Re‐feeding vs discarding gastric residuals

• Re‐feeding versus discarding gastric residuals to improve growth in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 59 participants
  Low

Summary of findings table ‐ Re‐feeding vs discarding gastric residuals

• Re‐feeding versus discarding gastric residuals to improve growth in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 59 participants
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

The review found no eligible studies for this question.

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Superoxide dismutase (SOD) vs placebo

It is very uncertain whether superoxide dismutase (SOD) changes BPD defined as an oxygen requirement at 28 days№ of participants:… compared with placebo (very low certainty).

• Superoxide dismutase for bronchopulmonary dysplasia in preterm infants 2023 · Cochrane Headline outcomes only
  RR 1.09 [0.94, 1.26]
  Studies not reported
  Very low

Superoxide dismutase (SOD) vs placebo

It is very uncertain whether superoxide dismutase (SOD) changes neonatal mortality (i.e. within 28 days)№ of participants: 335(2 RCTs) compared with placebo (very low certainty).

• Superoxide dismutase for bronchopulmonary dysplasia in preterm infants 2023 · Cochrane Headline outcomes only
  RR 0.98 [0.57, 1.68]
  Studies not reported
  Very low

Superoxide dismutase (SOD) vs placebo

The review found no eligible studies for this question.

• Superoxide dismutase for bronchopulmonary dysplasia in preterm infants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found